Supremes Rule Against LabCorp On Test Patent

CEO SUMMARY: It’s a bad news/good news outcome for pathologists and lab administrators hoping for clearer guidance on patents granted for DNA and other diagnostic technology. The bad news is that LabCorp gets no relief from lower court rulings that it infringed patents on homocysteine testing. The good news is that three justices wanted to …

Supremes Rule Against LabCorp On Test Patent Read More »

To access this post, you must purchase The Dark Report.

Supremes Rule Against LabCorp On Test Patent

One barrister believes there’s good news in the dissenting opinion of three justices

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month